Sanofi India Chief Departs, Sets Transformative Path
Outgoing Exec To Lead SeQuent Scientific
Sanofi India's managing director is moving on after an eventful innings that saw the company re-orient operations, moving out of certain non-strategic areas to focus on core therapies. Pre-pandemic early digital adoption appears to have played out well too for the French group’s listed Indian arm.
You may also be interested in...
Sanofi India – in which France’s Sanofi S.A. holds a controlling 60% stake – is to divest its Nutraceuticals business in a deal worth around $80m.
Zentiva is opening a dedicated Indian office in Mumbai to support the Ankleshwar manufacturing facility that it has just acquired from former parent company Sanofi.
A senior Parexel executive and ex-FDA pharmaceutical quality assessor emphasizes at a conclave why “first impressions matter now more than ever” as the agency deploys complex alternate inspections tools which the pandemic provided, and that companies need to ensure that they get things right the first time.